Spring til hovednavigation Spring til søgning Spring til hovedindhold

Dapagliflozin is associated with lower risk of cardiovascular events and all-cause mortality in people with type 2 diabetes (CVD-REAL Nordic) when compared with dipeptidyl peptidase-4 inhibitor therapy: a multinational observational study

  • F Persson
  • , Thomas Nyström
  • , Marit Eika Jørgensen
  • , B Carstensen
  • , Hanne L Gulseth
  • , Marcus Thuresson
  • , Peter Fenici
  • , David Nathanson
  • , Jan W Eriksson
  • , Anna Norhammar
  • , J Bodegard
  • , Kåre I Birkeland
195 Citationer (Scopus)

Fingeraftryk

Dyk ned i forskningsemnerne om 'Dapagliflozin is associated with lower risk of cardiovascular events and all-cause mortality in people with type 2 diabetes (CVD-REAL Nordic) when compared with dipeptidyl peptidase-4 inhibitor therapy: a multinational observational study'. Sammen danner de et unikt fingeraftryk.
Sorter

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science